Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

ABT MDT SYK ISRG Natural Foods Biotech Aggressive Corporate Bonds 
Benchmark SP 500  1,629   22.88  Index Moved Down -1.39% United States ...


Processing
Collecting data for NXTM

Nxstage discussions

 
 Companies |  Insiders  | Dashboard  
  
Add To Portfolio  add NXTM to portfolio
   

Nxstage Medical

Stock@NASDAQ 
United States USD
  
0.06 times
   
Use Nxstage Medical Inc discussions together with your other stock asset holdings to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.  Optimize Portfolio
       

Nxstage discussions

       
       

Currently Trending  

 SGC 
 NGM United States 
 Bought over 100 shares of  Superior Uniform Group Inc
 12 minutes ago
for 10.99 
 ACPW 
 NCM United States 
 Bought over 400 shares of  Active Power Inc
 12 minutes ago
for 4.28 
 ENTN 
 PNK United States 
 Bought over 200 shares of  Entorian Technologies Inc
 12 minutes ago
for 7.1 
 BOFI 
 NMS United States 
 Bought over 40 shares of  BofI Holding Inc
 12 minutes ago
for 48.97 
 WRLS 
 NMS United States 
 Bought over 100 shares of  Telular Corporation
 31 minutes ago
for 12.56 
 MPWR 
 NMS United States 
 Bought over 70 shares of  Monolithic Power Systems Inc
 31 minutes ago
for 24.69 
       
Chance of
Bankruptcy
Less
Than
1%
In The Next
Two Years
?
Nxstage Medical Inc has less than 1.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Check Z Score
View Details
Follow Nxstage Discussions with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
Get Widget
 
Add Nxstage to your reader
Syndicate
 

Nxstage Research Report

   
Generate Report Get Nxstage research report

Compare Nxstage To

Abbott  Medtronic  Stryker  Intuitive  Zimmer  St Jude  Boston  Smith  Edwards  Varian 
 Risk & Return  Correlation

Nxstage Selected Financial Ratios

Current Liabilities vs Book Value Per Share
Shares Owned by Insiders vs Cash and Equivalents
Current Liabilities vs EBITDA
Number of Shares Shorted vs Cash and Equivalents
Current Liabilities vs Price to Sales
Total Asset vs Cash and Equivalents
Current Liabilities vs Working Capital
Shares Outstanding vs Cash and Equivalents
 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
Take our survey
  
Financial Widget
Financial Widgets
Financial Content
Investing Content
Get Stock Ticker
Stock Tickers
 
Opportunities   Themes   Suggestions
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
  © 2013 Macroaxis Inc. All rights reserved       Custom Reporting   Advertising   Mobile Access   Retirement Grader   Alpha Search   Compare Stocks
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium